https://www.selleckchem.com/pr....oducts/pnd-1186-vs-4
Finally, anti-tumor immunity induced by LAG3-Ig-P5-immunoliposomes translated into the more tumor regression and prolonged survival of treated mice, compared to soluble immunotherapy. Taken together, our findings suggest that LAG3-Ig-P5-immunoliposomes can be considered as a valuable candidate for developing a liposome-based therapeutic cancer vaccine in treating HER2/ neu+ breast cancer patients. To establish predictive models for mortality in patients with polymyositis/dermatomyositis-associated interstitial lung disease (PM/
Like
Comment
Share
